WALDENSTROM'S MACROGLOBULINEMIA
Clinical trials for WALDENSTROM'S MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTROM'S MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTROM'S MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to tame rare blood cancer and prep for transplant
Disease control OngoingThis Phase 2 trial tests bortezomib (Velcade) and rituximab (Rituxan) as an initial treatment for Waldenstrom's macroglobulinemia, a rare blood cancer. The goal is to control the disease and collect stem cells for a possible future transplant. The study involves 46 participants a…
Matched conditions: WALDENSTROM'S MACROGLOBULINEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Scientists launch tissue bank to unlock secrets of rare blood cancers
Knowledge-focused OngoingThis study collects bone marrow and blood samples, along with medical history, from people with multiple myeloma, Waldenstrom macroglobulinemia, and related disorders. The samples are stored in a tissue bank for future research to understand what causes these cancers, how they pr…
Matched conditions: WALDENSTROM'S MACROGLOBULINEMIA
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:07 UTC